InfectivologyNews.net

Infectivology Xagena

Search results for "HIV patients"

Schering-Plough has discontinued a Phase II study with its investigational CCR5 receptor antagonist, Vicriviroc, used in combination with Combivir in treatment-naive HIV patients. This decision was ...


Taking daily Selenium supplements appears to increase the level of the essential mineral in the blood and may suppress the progression of viral load in patients with HIV infection. Advances in anti ...


A study to assess the adverse effects of anti-retroviral drugs has shown that two widely-used HIV drugs are associated with an increased risk of myocardial infarction and formation of blood clots in ...


A single subcutaneous injection of Canakinumab, a monoclonal antibody to the inflammation driver IL-1 beta, lowered inflammation in arteries of 10 people taking suppressive antiretroviral therapy ( AR ...